NEPHROCAREHospital
Nephro Care India Limited — Profit & Loss Statement
₹51.75
-8.81%
Nephro Care India Limited Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.00 | -83360.19 | 0.00 | — |
| Tax Rate For Calcs | 0.25 | 0.28 | 0.28 | 0.30 | — |
| Normalized EBITDA | 7.40 Cr | 6.84 Cr | 3.62 Cr | 0.13 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 3.64 Cr | 4.50 Cr | 1.94 Cr | -98000.00 | — |
| Reconciled Depreciation | 2.46 Cr | 0.53 Cr | 0.79 Cr | 0.11 Cr | — |
| Reconciled Cost Of Revenue | 13.06 Cr | 9.08 Cr | 4.88 Cr | 1.48 Cr | — |
| EBITDA | 7.40 Cr | 6.84 Cr | 3.59 Cr | 0.13 Cr | — |
| EBIT | 4.94 Cr | 6.31 Cr | 2.80 Cr | 0.01 Cr | — |
| Net Interest Income | -0.11 Cr | -0.09 Cr | -0.15 Cr | -0.01 Cr | — |
| Interest Expense | 0.11 Cr | 0.09 Cr | 0.09 Cr | 0.01 Cr | — |
| Normalized Income | 3.64 Cr | 4.50 Cr | 1.96 Cr | -98000.00 | — |
| Net Income From Continuing And Discontinued Operation | 3.64 Cr | 4.50 Cr | 1.94 Cr | -98000.00 | — |
| Total Expenses | 42.62 Cr | 21.29 Cr | 14.21 Cr | 3.41 Cr | — |
| Diluted NI Availto Com Stockholders | 3.64 Cr | 4.50 Cr | 1.94 Cr | -98000.00 | — |
| Net Income Common Stockholders | 3.64 Cr | 4.50 Cr | 1.94 Cr | -98000.00 | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 3.64 Cr | 4.50 Cr | 1.94 Cr | -98000.00 | — |
| Net Income Including Noncontrolling Interests | 3.64 Cr | 4.50 Cr | 1.94 Cr | -98000.00 | — |
| Net Income Continuous Operations | 3.64 Cr | 4.50 Cr | 1.94 Cr | -98000.00 | — |
| Tax Provision | 1.19 Cr | 1.72 Cr | 0.77 Cr | 0.01 Cr | — |
| Pretax Income | 4.83 Cr | 6.22 Cr | 2.71 Cr | 2000.00 | — |
| Other Non Operating Income Expenses | 1.53 Cr | 0.37 Cr | 7000.00 | 3000.00 | — |
| Net Non Operating Interest Income Expense | -0.11 Cr | -0.09 Cr | -0.15 Cr | -0.01 Cr | — |
| Interest Expense Non Operating | 0.11 Cr | 0.09 Cr | 0.09 Cr | 0.01 Cr | — |
| Operating Income | 3.41 Cr | 5.94 Cr | 2.89 Cr | 0.01 Cr | — |
| Operating Expense | 29.56 Cr | 12.21 Cr | 9.32 Cr | 1.93 Cr | — |
| Other Operating Expenses | 19.51 Cr | 9.52 Cr | 4.72 Cr | 1.03 Cr | — |
| Depreciation And Amortization In Income Statement | 2.46 Cr | 0.53 Cr | 0.79 Cr | 0.11 Cr | — |
| Depreciation Income Statement | 2.46 Cr | 0.53 Cr | 0.79 Cr | 0.11 Cr | — |
| Gross Profit | 32.97 Cr | 18.15 Cr | 12.21 Cr | 1.94 Cr | — |
| Cost Of Revenue | 13.06 Cr | 9.08 Cr | 4.88 Cr | 1.48 Cr | — |
| Total Revenue | 46.03 Cr | 27.23 Cr | 17.09 Cr | 3.42 Cr | — |
| Operating Revenue | 46.03 Cr | 27.23 Cr | 17.09 Cr | 3.42 Cr | — |
| Diluted Average Shares | — | 1.65 Cr | — | 1.65 Cr | 1.65 Cr |
| Basic Average Shares | — | 1.65 Cr | — | 1.65 Cr | 1.65 Cr |
| Diluted EPS | — | 2.73 | — | -0.01 | 0.05 |
| Basic EPS | — | 2.73 | — | -0.01 | 0.05 |
| Total Unusual Items | — | — | -0.03 Cr | 0.00 | 0.00 |
| Total Unusual Items Excluding Goodwill | — | — | -0.03 Cr | 0.00 | 0.00 |
| Interest Income | — | — | 17000.00 | 23000.00 | 78000.00 |
| Rent Expense Supplemental | — | — | 0.87 Cr | 0.38 Cr | 0.10 Cr |
| Special Income Charges | — | — | -0.03 Cr | 0.00 | 0.00 |
| Write Off | — | — | 0.03 Cr | 0.00 | 0.00 |
| Total Other Finance Cost | — | — | 0.06 Cr | 18000.00 | 11000.00 |
| Interest Income Non Operating | — | — | 17000.00 | 23000.00 | 78000.00 |
| Selling General And Administration | — | — | 1.81 Cr | 0.10 Cr | 0.02 Cr |
| Selling And Marketing Expense | — | — | 0.07 Cr | 67000.00 | 0.00 |
| General And Administrative Expense | — | — | 1.74 Cr | 0.09 Cr | 0.02 Cr |
| Rent And Landing Fees | — | — | 0.87 Cr | 0.38 Cr | 0.10 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Nephro Care India Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.